CLINICAL ROLE -
Rx Product News Profile: A Closer Look at New FDA Actions: Novo Nordisk's Victoza
Novo Nordisk's Victoza (liraglutide), the first glucagon-like peptide-1 receptor agonist subcutaneous injection, received FDA approval for the treatment of type 2 diabetes mellitus.
Read More